Alnylam Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
ALNY chart
What traders are saying about $ALNY
Latest postsAlnylam Pharmaceuticals, Inc. news
- Alnylam Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $298, Implies 91% Upside
TradingView ·
- Citi Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Cuts Target Price to $250
Moomoo ·
- Alnylam Pharmaceuticals, Inc. (ALNY) stock price, news, quote and history
Yahoo Finance Singapore ·
- Alnylam Announces Five-Year HELIOS-B Data Demonstrating Sustained Benefit of AMVUTTRA® (vutrisiran) in ATTR-CM
Yahoo Finance ·
- Weekly Recap: $1 billion buyback authorized and Truist downgrades to Hold
TradingView ·
- Alnylam Pharmaceuticals (ALNY) Faces A Valuation Test After Fresh AMVUTTRA Data
Simply Wall St ·
- Alnylam Pharmaceuticals (ALNY) Stock Price, Chart & Analysis
www.debelegger.nl ·
- We Believe Alnylam Pharmaceuticals' (NASDAQ:ALNY) Earnings Are A Poor Guide For Its Profitability
Simply Wall St ·
- What Is Behind The Rise In Moderna Stock?
trefis.com ·
- Alnylam Pharmaceuticals Inc (ALNY) Stock Price, Quote, News & History
Benzinga ·
- Alnylam Pharmaceuticals stock hits 52-week low at $155.22 By Investing.com
Investing.com Nigeria ·
- Alnylam Pharmaceuticals stock hits 52-week low at $155.22
Investing.com ·
Alnylam Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.71B | $2.25B | $1.83B | $1.04B |
| Net income | $313.7M | -$278.2M | -$440.2M | -$1.13B |
| Diluted EPS | $2.33 | $-2.18 | $-3.52 | $-9.30 |
| Total assets (year end) | $4.97B | $4.24B | $3.83B | $3.55B |
| Cash and equivalents (year end) | $1.66B | $966.4M | $812.7M | $866.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Alnylam Pharmaceuticals, Inc.
- Ticker
- ALNY (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Fiscal year end
- December 31
- SEC CIK
- 1178670
- Former names
- ALNYLAM PHARMACEUTICALS INC
Frequently asked questions
What exchange is Alnylam Pharmaceuticals, Inc. listed on?
Alnylam Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol ALNY.
What industry is Alnylam Pharmaceuticals, Inc. in?
Alnylam Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Alnylam Pharmaceuticals, Inc. headquartered?
Alnylam Pharmaceuticals, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Alnylam Pharmaceuticals, Inc.'s fiscal year end?
Alnylam Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Alnylam Pharmaceuticals, Inc. report?
Alnylam Pharmaceuticals, Inc. reported $3.71B in revenue for calendar year 2025, according to its SEC filings.